http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104490869-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-365 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 |
| filingDate | 2014-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104490869-B |
| titleOfInvention | III derivative of atractylodes lactone is in the drug for preparing application and anti-platelet aggregation in anti-platelet aggregation drug |
| abstract | The present invention relates to a kind of medicament for resisting platelet aggregation, including III derivative of atractylodes lactone as shown in structural formula 1: The invention further relates to application of III derivative of atractylodes lactone in the drug for preparing platelet aggregation-against.It is simple that the present invention provides a kind of composition, and the drug with platelet aggregation-against generated by the effective component extracts of the effective component of natural medicinal raw material or its medicinal raw material, with good effect, have no toxic side effect, be not likely to produce tolerance, and it is convenient to take be generally applicable to by platelet aggregation rate it is excessively high caused by blood viscousness and the problems such as thrombus. |
| priorityDate | 2014-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 92.